Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074
- Supplementary File 1:
PDF-Document (PDF, 2900 KiB)
Englinger, B.; Kallus, S.; Senkiv, J.; Laemmerer, A.; Moser, P.; Gabler, L.; Groza, D.; Kowol, C.R.; Heffeter, P.; Grusch, M.; Berger, W. Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074. Cells 2018, 7, 259. https://doi.org/10.3390/cells7120259
Englinger B, Kallus S, Senkiv J, Laemmerer A, Moser P, Gabler L, Groza D, Kowol CR, Heffeter P, Grusch M, Berger W. Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074. Cells. 2018; 7(12):259. https://doi.org/10.3390/cells7120259
Chicago/Turabian StyleEnglinger, Bernhard; Kallus, Sebastian; Senkiv, Julia; Laemmerer, Anna; Moser, Patrick; Gabler, Lisa; Groza, Diana; Kowol, Christian R.; Heffeter, Petra; Grusch, Michael; Berger, Walter. 2018. "Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074" Cells 7, no. 12: 259. https://doi.org/10.3390/cells7120259